Gravity Analytica

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ARDX 01.06.2025

SERA-AI Powered Highlights

Date of Upcoming Event:2025-01-15

Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference

Full Press Release SEC Filings Our ARDX Tweets

About Gravity Analytica

Recent Filings

WALTHAM, Mass.,Jan. 06, 2025(GLOBE NEWSWIRE) --Ardelyx, Inc.(Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced thatMike Raab, President and CEO, will present at the 43^rdAnnualJ.P. Morgan Healthcare ConferenceonWednesday, January 15, 2025at4:30pm PTinSan Francisco.

To access the live webcast of the panel presentation please visit the Events and Presentations page within theArdelyxwebsite athttps://ir.ardelyx.com/events-and-presentations. A replay of the panel presentation will be available on theArdelyxwebsite for 30 days following the event.

AboutArdelyx, Inc.Ardelyxwas founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.Ardelyxhas two commercial products approved inthe United States, IBSRELA^®(tenapanor) and XPHOZAH^®(tenapanor).Ardelyxhas agreements for the development and commercialization of tenapanor outside of theU.S.Kyowa Kirin commercializes PHOZEVEL^®(tenapanor) for hyperphosphatemia inJapan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted inChinawith Fosun Pharma. Knight Therapeutics commercializes IBSRELA inCanada. For more information, please visithttps://ardelyx.com/and connect with us onX (formerly known as Twitter),LinkedInandFacebook.

Investor and Media Contacts:Caitlin Lowieclowie@ardelyx.com

Source: Ardelyx, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com